NCT00728910View on ClinicalTrials.gov

Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Dyslipidemia
Interventions
DRUG

Atorvastatin

10 mg QD for 4 weeks

DRUG

ABT335

135 mg QD added to atorvastatin for 8 weeks

DRUG

ER Niacin

2000 mg QD added to atorvastatin and ABT335 for 10 weeks

Trial Locations (1)

19104

CTRC (Clinical Translational Research Center), Philadelphia

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Pennsylvania

OTHER